Bath & Body Works (NYSE:BBWI) has sustained a positive performance over the years outpacing its underlying earnings growth. Argus and Wells Fargo have both affirmed their rating for the company, with the latter even upgrading it. The company has showcased its global retail strength by maintaining a $0.20 dividend. BBWI topped Q3 earnings and revenue estimates reflecting a steady growth. Additionally, its inventories stand at a robust $1,178 million. The company's strong performance has led to its shares soaring, with Wells Fargo predicting more upside. The company's Q3 sales have risen by 3% to $1.61 billion and it has raised its full-year outlook. Despite challenges, BBWI's stock remains resilient and it has seen strong candle day performance, according to Goldman Sachs, the company is undervalued. The company's growth is improving but not enough for a rating upgrade. BBWI, improving customer experiences and delivering growth through next-gen technology and AI has partnered with Accenture. Despite certain disappointments in guidance and foreseen short-term weaknesses, Bath & Body Works continues to show potential in the long term.
Bath Body Works BBWI News Analytics from Thu, 23 May 2024 07:00:00 GMT to Fri, 10 Jan 2025 16:26:32 GMT -
Rating 7
- Innovation 4
- Information 8
- Rumor -3
